Regulatory Approaches for Control of Viral Contamination of Vaccines

References

1. 1.↵
   U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research. Characterization and Qualification of Cell Substrates and Other Biological Materials Used in the Production of Viral Vaccines for Infectious Disease Indications. 2010.
2. 2.↵
   1. Sweet B. H.,
   2. Hilleman M. R.

   The Vacuolating Virus, SV40. Proceedings of the Society for Experimental Biology and Medicine 1960, 105 (2), 420–427.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Sierra-Honigmann A.,
   2. Krause P. R.

   Live oral poliovirus vaccines do not contain detectable simian virus 40 (SV40) DNA. Biologicals 2000, 28 (1), 1–4.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Strickler H. D.,
   2. Rosenberg P. S.,
   3. Devesa S. S.,
   4. Hertel J.,
   5. Fraumeni J. F.,
   6. Goedert J. J.

   Contamination of poliovirus vaccines with simian virus 40 (1955–1963) and subsequent cancer rates. JAMA—Journal of the American Medical Association 1998, 279 (4), 292–295.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Strickler H. D.,
   2. Goedert J. J.,
   3. Butel J. S.,
   4. Daniel R.,
   5. Freymuth F.,
   6. Gibbs A.,
   7. Griffiths D. J.,
   8. Jablons D.,
   9. Jasani B.,
   10. Jones C.,
   11. Lednicky J. A.,
   12. Miller C. W.,
   13. Radu C.,
   14. Richards W. G.,
   15. Shah K. V.,
   16. You L.,
   17. Corson J. M.,
   18. Gerwin B.,
   19. Harris C.,
   20. Sugarbaker D. J.,
   21. Egan W.,
   22. Lewis A. M.,
   23. Krause P. R.,
   24. Peden K.,
   25. Levine A. S.,
   26. Melnick S.,
   27. Cosentino M.,
   28. da Costa M.,
   29. Devairrakam V.,
   30. Ji J.,
   31. Palefsky J.,
   32. Rasmussen L.,
   33. Shea K.,
   34. Wacholder S.,
   35. Waters D.,
   36. Wright T.

   A multicenter evaluation of assays for detection of SV40 DNA and results in masked mesothelioma specimens. Cancer Epidemiology Biomarkers & Prevention 2001, 10 (5), 523–532.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Boni J.,
   2. Stalder J.,
   3. Reigel F.,
   4. Schupbach J.

   Detection of reverse transcriptase activity in live attenuated virus vaccines. Clinical and Diagnostic Virology 1996, 5 (1), 43–53.

   OpenUrlPubMed
7. 7.↵
   1. Khan A. S.,
   2. Maudru T.,
   3. Thompson A.,
   4. Muller J.,
   5. Sears J. F.,
   6. Peden K. W. C.

   The reverse transcriptase activity in cell-free medium of chicken embryo fibroblast cultures is not associated with a replication-competent retrovirus. Journal of Clinical Virology 1998, 11 (1), 7–18.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Robertson J. S.,
   2. Nicolson C.,
   3. Riley A. M.,
   4. Bentley M.,
   5. Dunn G.,
   6. Corcoran T.,
   7. Schild G. C.,
   8. Minor P.

   Assessing the significance of reverse transcriptase activity in chick cell-derived vaccines. Biologicals 1997, 25 (4), 403–414.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Hussain A. I.,
   2. Johnson J. A.,
   3. Freire M. D.,
   4. Heneine W.

   Identification and characterization of avian retroviruses in chicken embryo-derived yellow fever vaccines: Investigation of transmission to vaccine recipients. Journal of Virology 2003, 77 (2), 1105–1111.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Tsang S. X.,
    2. Switzer W. M.,
    3. Shanmugam V.,
    4. Johnson J. A.,
    5. Goldsmith C.,
    6. Wright A.,
    7. Fadly A.,
    8. Thea D.,
    9. Jaffe H.,
    10. Folks T. H.,
    11. Heneine W.

    Evidence of avian leukosis virus subgroup E and endogenous avian virus in measles and mumps vaccines derived from chicken cells: Investigation of transmission to vaccine recipients. Journal of Virology 1999, 73 (7), 5843–5851.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    Reverse transcriptase activity in chicken-cell derived vaccine. Weekly Epidemiol Rec 1998, 73 (28), 209–212.

    OpenUrlPubMed
12. 12.↵
    1. Victoria J. G.,
    2. Wang C. L.,
    3. Jones M. S.,
    4. Jaing C.,
    5. McLoughlin K.,
    6. Gardner S.,
    7. Delwart E. L.

    Viral Nucleic Acids in Live-Attenuated Vaccines: Detection of Minority Variants and an Adventitious Virus. Journal of Virology 2010, 84 (12), 6033–6040.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. McClenahan S. D.,
    2. Krause P. R.,
    3. Uhlenhaut C.

    Molecular and infectivity studies of porcine circovirus in vaccines. Vaccine 2011, 29 (29–30), 4745–4753.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Kuehn B. M.

    FDA: Benefits of Rotavirus Vaccination Outweigh Potential Contamination Risk. JAMA—Journal of the American Medical Association 2010, 304 (1), 30–31.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    Vaccines and Related Biological Products Advisory Committee. Finding of PCV DNA Sequences in Rotavirus Vaccines. May 7, 2010.
16. 16.↵
    1. Onions D.,
    2. Kolman J.

    Massively parallel sequencing, a new method for detecting adventitious agents. Biologicals 2010, 38 (3), 377–380.

    OpenUrlPubMed
17. 17.↵
    1. Nanda S.,
    2. Jayan G.,
    3. Voulgaropoulou F.,
    4. Sierra-Honigmann A. M.,
    5. Uhlenhaut C.,
    6. McWatters B. J. P.,
    7. Patel A.,
    8. Krause P. R.

    Universal virus detection by degenerate-oligonucleotide primed polymerase chain reaction of purified viral nucleic acids. Journal of Virological Methods 2008, 152 (1–2), 18–24.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Uhlenhaut C.,
    2. Cohen J. I.,
    3. Fedorko D.,
    4. Nanda S.,
    5. Krause P. R.

    Use of a universal virus detection assay to identify human metapneumovirus in a hematopoietic stem cell transplant recipient with pneumonia of unknown origin. Journal of Clinical Virology 2009, 44 (4), 337–339.

    OpenUrlPubMed
19. 19.↵
    1. Eckert D. J.,
    2. Sampath R.,
    3. Li H. J.,
    4. Massire C.,
    5. Matthews H. E.,
    6. Toleno D.,
    7. Hall T. A.,
    8. Blyn L. B.,
    9. Eshoo M. W.,
    10. Ranken R.,
    11. Hofstadler S. A.,
    12. Tang Y. W.

    New technology for rapid molecular diagnosis of bloodstream infections. Expert Review of Molecular Diagnostics 2010, 10 (4), 399–415.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Miller S.,
    2. Barker C.,
    3. Hoo Y.,
    4. Erle D.,
    5. Barczak A.,
    6. Fischer K.,
    7. DeRisi J.,
    8. Chiu C.

    Establishing a microarray test for pan-viral identification (Virochip) as a core laboratory resource at UCSF. American Journal of Clinical Pathology 2008, 130 (3), 475.

    OpenUrl